A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce

Abstract Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nikki Carter, Maryam Clausen, Rebecca A. Halpin, Colin Blackmore, Kang Cai, Oona Delpuech, Alexander Kohlmann, Otto Magnusson, Ruth March, Daniel O’Neill, Kasthuri Prakash, James Sherwood, Tabetha Sundin, Jason Swift, Azar Tarakameh, Marilou Wijdicks, Daniel Wise, Mark Fidock
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/cd949d71d09d40a391ffbdef580d8d56
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce

Ejemplares similares